ERBB2 and breast cancer: In MMTV-ErbB2/neu and MMTV-PyMTV models, Maroulakou et al. 26 reported that AKT1 ablation delays tumor formation, but has no effect on metastasis, whereas AKT2 ablation enhances mammary tumor growth.